With an additional 5M in cash burn last Q it's hard to reconcile how expenses went down Q4 over Q3. Perhaps they are ammoritizing upfront loan expense over the ten year term of the loan?
Anyway at -.28/sh they beat consensus to the upside by slightly more than Saltland and I thought they'd miss on the downside. Getting tougher and tougher to make projections here.
But they still haven't been close to consensus estimate EPS up or down in the past 5 quarters. That's simply poor guidance. Need to fix it.
Ann: AVITA Medical Reports Q4 and Full-Year 2023 Results, page-2
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.70 |
Change
-0.010(0.37%) |
Mkt cap ! $167.8M | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.74 | $2.68 | $913.8K | 336.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3704 | $2.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.70 | 10305 | 2 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.71 |
Change
-0.010 ( 0.90 %) |
||||
| Open | High | Low | Volume | ||
| $2.73 | $2.74 | $2.68 | 11334 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| AVH (ASX) Chart |